OR2C3
geneOn this page
Also known as OST742
Summary
OR2C3 (olfactory receptor family 2 subfamily C member 3, HGNC:15005) is a protein-coding gene on chromosome 1q44, encoding Olfactory receptor 2C3 (Q8N628). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 81472 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 3 total
- MANE Select transcript:
NM_198074
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15005 |
| Approved symbol | OR2C3 |
| Name | olfactory receptor family 2 subfamily C member 3 |
| Location | 1q44 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | OST742 |
| Ensembl gene | ENSG00000196242 |
| Ensembl biotype | protein_coding |
| Entrez | 81472 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000366487, ENST00000641802, ENST00000673193
RefSeq mRNA: 1 — MANE Select: NM_198074
NM_198074
CCDS: CCDS1634
Canonical transcript exons
ENST00000641802 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001828853 | 247524677 | 247532540 |
| ENSE00003811703 | 247533507 | 247533878 |
| ENSE00003811954 | 247536168 | 247536440 |
Expression profiles
Bgee: expression breadth broad, 55 present calls, max score 71.52.
Top tissues by expression
109 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 71.52 | gold quality |
| ventricular zone | UBERON:0003053 | 53.79 | gold quality |
| ganglionic eminence | UBERON:0004023 | 51.82 | silver quality |
| mucosa of stomach | UBERON:0001199 | 49.58 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 48.78 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 48.67 | gold quality |
| placenta | UBERON:0001987 | 47.81 | gold quality |
| cortical plate | UBERON:0005343 | 46.87 | gold quality |
| testis | UBERON:0000473 | 46.70 | gold quality |
| endometrium | UBERON:0001295 | 46.39 | silver quality |
| right testis | UBERON:0004534 | 46.26 | gold quality |
| gall bladder | UBERON:0002110 | 45.70 | gold quality |
| muscle tissue | UBERON:0002385 | 45.51 | gold quality |
| islet of Langerhans | UBERON:0000006 | 45.35 | gold quality |
| leukocyte | CL:0000738 | 45.29 | silver quality |
| left testis | UBERON:0004533 | 45.22 | gold quality |
| monocyte | CL:0000576 | 45.08 | silver quality |
| bone marrow cell | CL:0002092 | 44.30 | gold quality |
| vermiform appendix | UBERON:0001154 | 43.76 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 43.65 | gold quality |
| myometrium | UBERON:0001296 | 42.50 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 42.42 | gold quality |
| lymph node | UBERON:0000029 | 41.74 | gold quality |
| prostate gland | UBERON:0002367 | 41.61 | gold quality |
| bone marrow | UBERON:0002371 | 41.42 | gold quality |
| primary visual cortex | UBERON:0002436 | 41.42 | gold quality |
| colonic epithelium | UBERON:0000397 | 41.31 | gold quality |
| urinary bladder | UBERON:0001255 | 40.80 | silver quality |
| sural nerve | UBERON:0015488 | 39.89 | gold quality |
| calcaneal tendon | UBERON:0003701 | 39.79 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 2.95 |
| E-MTAB-6386 | no | 3.61 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
37 targeting OR2C3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-4692 | 100.00 | 67.32 | 2066 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-4514 | 99.99 | 67.10 | 1870 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-LET-7F-2-3P | 99.98 | 70.98 | 2588 |
| HSA-MIR-1185-1-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-1185-2-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-338-5P | 99.92 | 72.34 | 2951 |
| HSA-MIR-589-3P | 99.91 | 69.62 | 2088 |
| HSA-MIR-374A-5P | 99.90 | 71.34 | 2923 |
| HSA-MIR-374B-5P | 99.90 | 69.98 | 2734 |
| HSA-MIR-1323 | 99.83 | 69.89 | 2471 |
| HSA-MIR-202-5P | 99.78 | 67.65 | 991 |
| HSA-MIR-1299 | 99.77 | 71.24 | 2389 |
| HSA-MIR-548O-3P | 99.74 | 69.30 | 2228 |
| HSA-MIR-875-3P | 99.63 | 69.47 | 2548 |
| HSA-MIR-302B-5P | 99.50 | 69.49 | 1857 |
| HSA-MIR-302D-5P | 99.50 | 69.34 | 1863 |
| HSA-MIR-8064 | 99.45 | 66.92 | 875 |
| HSA-MIR-4735-5P | 99.43 | 68.49 | 1780 |
| HSA-MIR-16-2-3P | 99.29 | 70.60 | 1954 |
| HSA-MIR-195-3P | 99.29 | 70.61 | 1954 |
| HSA-MIR-371A-5P | 99.08 | 66.51 | 1914 |
| HSA-MIR-320A-5P | 98.88 | 66.75 | 1248 |
| HSA-MIR-655-5P | 98.74 | 65.93 | 888 |
Cross-species orthologs
0 orthologs
Paralogs (92): OR2B6 (ENSG00000124657), OR13C9 (ENSG00000136839), OR13C4 (ENSG00000148136), OR2M5 (ENSG00000162727), OR10A5 (ENSG00000166363), OR2D2 (ENSG00000166368), OR2B2 (ENSG00000168131), OR2C1 (ENSG00000168158), OR13J1 (ENSG00000168828), OR10G3 (ENSG00000169208), OR10A3 (ENSG00000170683), OR10A4 (ENSG00000170782), OR10A2 (ENSG00000170790), OR13H1 (ENSG00000171054), OR2K2 (ENSG00000171133), OR2M4 (ENSG00000171180), OR10H2 (ENSG00000171942), OR10H5 (ENSG00000172519), OR10AD1 (ENSG00000172640), OR2Y1 (ENSG00000174339), OR10AG1 (ENSG00000174970), OR2T1 (ENSG00000175143), OR10P1 (ENSG00000175398), OR2T35 (ENSG00000177151), OR2M7 (ENSG00000177186), OR2T12 (ENSG00000177201), OR2T33 (ENSG00000177212), OR2AJ1 (ENSG00000177275), OR2T8 (ENSG00000177462), OR2G3 (ENSG00000177476), OR2G2 (ENSG00000177489), OR2B11 (ENSG00000177535), OR2D3 (ENSG00000178358), OR13D1 (ENSG00000179055), OR10A7 (ENSG00000179919), OR2Z1 (ENSG00000181733), OR2V2 (ENSG00000182613), OR10G7 (ENSG00000182634), OR2T29 (ENSG00000182783), OR2T34 (ENSG00000183310)
Protein
Protein identifiers
Olfactory receptor 2C3 — Q8N628 (reviewed: Q8N628)
Alternative names: Olfactory receptor 2C4, Olfactory receptor 2C5, Olfactory receptor OR1-30
All UniProt accessions (1): Q8N628
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_932340* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF13853
UniProt features (22 total): topological domain 8, transmembrane region 7, sequence variant 4, chain 1, glycosylation site 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N628-F1 | 86.84 | 0.62 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 98–190
Glycosylation sites (1): 6
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 37 (showing top):
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_UP, GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, chr1q44, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, MARTENS_TRETINOIN_RESPONSE_UP, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, MIR302C_5P, MIR4692
GO Biological Process (4): detection of chemical stimulus involved in sensory perception of smell (GO:0050911), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
120 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR2C3 | GCSAML | Q5JQS6 | 432 |
| OR2C3 | TMEM232 | C9JQI7 | 377 |
| OR2C3 | KLHL29 | Q96CT2 | 377 |
| OR2C3 | KRT85 | P78386 | 348 |
| OR2C3 | CPLX3 | Q8WVH0 | 327 |
| OR2C3 | PKIB | Q9C010 | 311 |
| OR2C3 | NPFFR1 | Q9GZQ6 | 307 |
| OR2C3 | ST6GALNAC3 | Q8NDV1 | 301 |
| OR2C3 | ARID5B | Q14865 | 296 |
| OR2C3 | ZRANB2 | O95218 | 295 |
| OR2C3 | KCNE4 | Q8WWG9 | 274 |
| OR2C3 | SEPTIN8 | Q92599 | 273 |
| OR2C3 | MAIP1 | Q8WWC4 | 248 |
| OR2C3 | RIN3 | Q8TB24 | 223 |
| OR2C3 | EIF2S2 | P20042 | 211 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A2R8YED5, A6NM03, O14581, O60412, O76099, O95006, O95047, O95371, P34982, P34984, P47884, P58170, Q15619, Q15622, Q5TZ20, Q60883, Q60887, Q60891, Q6IFH4, Q7Z3T1, Q8N628, Q8NG84, Q8NG95, Q8NG98, Q8NG99, Q8NGA0, Q8NGA1, Q8NGA2, Q8NGQ5, Q8NGR9, Q8NGS1, Q8NGS2, Q8NGS3, Q8NGV0, Q8NGW1, Q8NGX1, Q8NH06, Q8NH80, Q8NHA4, Q95157
Diamond homologs: A0A096LPK9, A0A0X1KG70, A6NHA9, A6NMZ5, O60412, O76099, O95013, P0C604, P0C623, P0C645, P0DN82, P23270, P23275, P58173, P58180, P58182, Q15615, Q60878, Q60881, Q60888, Q6IEV9, Q6IEY1, Q6IF82, Q7TQQ0, Q8IXE1, Q8N0Y3, Q8N628, Q8NGA8, Q8NGB2, Q8NGB4, Q8NGB6, Q8NGB8, Q8NGB9, Q8NGC2, Q8NGC3, Q8NGC4, Q8NGC6, Q8NGD0, Q8NGD1, Q8NGD2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
3 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 3 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
434 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:247533506:CCTTA:C | donor_gain | 0.9900 |
| 1:247525960:GA:G | donor_gain | 0.9800 |
| 1:247532540:CCTG:C | acceptor_loss | 0.9800 |
| 1:247532541:C:A | acceptor_loss | 0.9800 |
| 1:247532542:T:C | acceptor_loss | 0.9800 |
| 1:247533502:CCTA:C | donor_loss | 0.9800 |
| 1:247533504:TA:T | donor_loss | 0.9800 |
| 1:247533505:A:AG | donor_loss | 0.9800 |
| 1:247533506:C:A | donor_loss | 0.9800 |
| 1:247533510:A:AC | donor_gain | 0.9800 |
| 1:247533511:C:CC | donor_gain | 0.9800 |
| 1:247525333:GGC:G | donor_gain | 0.9500 |
| 1:247532538:CAC:C | acceptor_gain | 0.9500 |
| 1:247533600:T:TA | donor_gain | 0.9500 |
| 1:247526938:AG:A | acceptor_gain | 0.9400 |
| 1:247526939:GG:G | acceptor_gain | 0.9400 |
| 1:247533505:A:AC | donor_gain | 0.9400 |
| 1:247533506:C:CC | donor_gain | 0.9400 |
| 1:247525907:GATT:G | donor_gain | 0.9200 |
| 1:247532537:CCAC:C | acceptor_gain | 0.9200 |
| 1:247532538:CACC:C | acceptor_gain | 0.9200 |
| 1:247532536:GCCAC:G | acceptor_gain | 0.9100 |
| 1:247532537:CCACC:C | acceptor_gain | 0.9100 |
| 1:247532541:C:CC | acceptor_gain | 0.9100 |
| 1:247527050:CTGAG:C | donor_loss | 0.9000 |
| 1:247527051:TGAG:T | donor_loss | 0.9000 |
| 1:247527052:GAGGT:G | donor_loss | 0.9000 |
| 1:247527053:AGG:A | donor_loss | 0.9000 |
| 1:247527054:GG:G | donor_loss | 0.9000 |
| 1:247527055:GTAC:G | donor_loss | 0.9000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000005905 (1:247531025 G>C,T), RS1000236980 (1:247524698 T>G), RS1000610833 (1:247526153 T>G), RS1000963501 (1:247537281 G>A), RS1001275832 (1:247529735 T>G), RS1001439181 (1:247535140 T>C), RS1001845824 (1:247525729 TCTG>T), RS1002281482 (1:247527990 G>A), RS1002333936 (1:247527738 G>A,C,T), RS1002516163 (1:247533010 G>T), RS1002824786 (1:247537374 G>A), RS1002852594 (1:247533692 T>C), RS1003011278 (1:247530818 C>A,G), RS1003063389 (1:247537159 A>G,T), RS1003165513 (1:247536490 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000464_11 | Acute lymphoblastic leukemia (childhood) | 7.000000e-06 |
| GCST90016667_32 | Spleen volume | 3.000000e-09 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Asbestos, Crocidolite | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): acute lymphoblastic leukemia